Published in Obstet Gynecol on April 01, 2014
Educating the Psychology Workforce in the Age of the Affordable Care Act: A Graduate Course Modeled after the Priorities of the Patient-Centered Outcomes Research Institute (PCORI). Train Educ Prof Psychol (2015) 0.77
Change in sexual behavior with provision of no-cost contraception: health reform in action: updates on implementation of the affordable care act. Obstet Gynecol (2014) 0.75
Consequences of a primary elective cesarean delivery across the reproductive life. Obstet Gynecol (2013) 2.09
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia. Blood (2010) 1.67
Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy. Leuk Lymphoma (2012) 1.40
A suggested approach for implementing CONSORT guidelines specific to obstetric research. Obstet Gynecol (2013) 1.38
Variations in the incidence of postpartum hemorrhage across hospitals in California. Matern Child Health J (2005) 1.30
Reductive processes controlling arsenic retention: revealing the relative importance of iron and arsenic reduction. Environ Sci Technol (2008) 1.24
Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC). Lung Cancer (2008) 1.06
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States. Ann Hematol (2015) 0.96
Innovative strategies to reduce disparities in the quality of prenatal care in underresourced settings. Med Care Res Rev (2010) 0.95
Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma. Leuk Lymphoma (2008) 0.89
Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database. Ann Hematol (2014) 0.89
Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia. Leuk Lymphoma (2011) 0.86
The association of rash severity with overall survival: findings from patients receiving erlotinib for pancreatic cancer in the community setting. Pancreas (2013) 0.83
Budget impact model of adding erlotinib to a regimen of gemcitabine for the treatment of locally advanced, nonresectable or metastatic pancreatic cancer. Clin Ther (2008) 0.83
Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy. Am J Hematol (2010) 0.82
Hospital rates of maternal and neonatal infection in a low-risk population. Matern Child Health J (2005) 0.82
Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer. J Gastrointest Cancer (2013) 0.81
Histopathologic and Radiologic Assessment of Chemotherapeutic Response in Ewing's Sarcoma: A Review. Sarcoma (2012) 0.80
Treatment patterns and outcomes among patients with metastatic melanoma treated in community practice. Int J Dermatol (2014) 0.79
HER2 in well differentiated breast cancer: is testing necessary? Breast Cancer Res Treat (2008) 0.78
Symptom Burden and Quality of Life in Patients with Follicular Lymphoma undergoing Maintenance Treatment with Rituximab Compared with Observation. Ther Adv Hematol (2011) 0.78
Economic impact of disease progression in follicular non-Hodgkin lymphoma. Leuk Lymphoma (2011) 0.78
Costs and clinical outcomes among patients with second-line non-small cell lung cancer in the outpatient community setting. J Thorac Oncol (2012) 0.77
Emerging organic contaminant removal depending on primary treatment and operational strategy in horizontal subsurface flow constructed wetlands: influence of redox. Water Res (2012) 0.77
A Framework for the Development of maternal quality of care indicators. Matern Child Health J (2005) 0.77
Age distribution of patients with advanced non-melanoma skin cancer in the United States. Arch Dermatol Res (2013) 0.77
Gestational pyelonephritis as an indicator of the quality of ambulatory maternal health care services. Obstet Gynecol (2006) 0.77
Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer. J Med Econ (2011) 0.77
Comparing variation in hospital rates of cesarean delivery among low-risk women using 3 different measures. Am J Obstet Gynecol (2015) 0.75
Development and validation of a preference weight multiattribute health outcome measure for rheumatoid arthritis. J Rheumatol (2006) 0.75
Measuring preference weights for American college of rheumatology response criteria for patients with rheumatoid arthritis. J Rheumatol (2005) 0.75
Building a better safety net: taking the safety agenda to office-based women's health. Obstet Gynecol (2012) 0.75
Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma. Hematology (2014) 0.75